NAV
$47.78
AUM
$264.9M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.68
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +15.91% | +3.09% | +10.37% | +30.51% | +20.39% | +12.21% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 4.75% |
| 2 | 005930.KS | Samsung Electronics Co Ltd | 2.55% |
| 3 | 000660.KS | SK Hynix Inc | 2.22% |
| 4 | ASML.AS | ASML Holding NV | 1.62% |
| 5 | 0700.HK | Tencent Holdings Ltd | 0.87% |
| 6 | HSBA.L | HSBC Holdings PLC | 0.83% |
| 7 | ROP.SW | Roche Holding AG Ordinary Shares new | 0.76% |
| 8 | AZN.L | AstraZeneca PLC | 0.73% |
| 9 | NOVN.SW | Novartis AG Registered Shares | 0.71% |
The fund, using a "passive" or indexing investment approach, seeks investment results that correspond generally to the performance, of the underlying index, which is designed to track the performance of equity securities in developed and emerging stock markets while mitigating exposure to fluctuations between the value of the USD and the currencies of the countries included in the underlying index. It will invest at least 80% of its total assets in component securities of the underlying index. It is non-diversified.
Inception Date: 2014-01-22